News Sentiment

MDLN sentiment intelligence

Medline Inc. Class A Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 44 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 41.04 Week of 10 Jul 2026
Weighted tone 44/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 59

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-5.0% over one week, +12.1% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Sumitomo Mitsui Trust Group Inc. Acquires New Shares in Medline $MDLN

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -5.0% Price reacting lower
Trend fit Trend inactive 12.1% over four weeks
Fair value -2.7% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 34
Negative 16

Relevance

Why the article matched

Direct first
Direct company coverage 59
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 12
Market source 9
NewMediaWire 8
Quiver Quantitative 4
MarketBeat 3
The Globe and Mail 3
PR Newswire 3
TradingView 3

Event Lens

What the news is about

Classified themes
Market update 37
Regulatory and legal 9
Earnings 6
Analyst action 3
Deals and strategy 2
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59
The Globe and Mail Direct company coverage

Investors of Medline Inc. (NASDAQ: MDLN) are Encouraged to Contact Kaplan Fox Regarding the Investigation of Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Medline Inc. (NASDAQ: MDLN) following a warning letter from the FDA. The FDA letter cited "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals,"

Tone
Negative 13/100
Event
Regulatory and legal
Published
20 Jun 2026 12:10
Source
The Globe and Mail
NewMediaWire Direct company coverage

Kaplan Fox is Investigating Potential Securities Law Violations Against Medline Inc. (NASDAQ: MDLN)

Kaplan Fox & Kilsheimer LLP is investigating potential securities law violations against Medline Inc. (NASDAQ: MDLN) following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and inadequate investigation int

Tone
Negative 14/100
Event
Regulatory and legal
Published
19 Jun 2026 19:40
Source
NewMediaWire
Stock Titan Direct company coverage

Medline (MDLN) executive has 1,308 shares withheld to cover RSU taxes

Medline Inc. executive William J. Abrams had 1,308 shares of Class A Common Stock withheld at $36.61 each to cover tax liabilities associated with the vesting of restricted stock units. This transaction, occurring on June 15, 2026, was a routine tax withholding and not an open-ma

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 10:09
Source
Stock Titan
PR Newswire Direct company coverage

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Industries, Inc. - MDLN

Pomerantz LLP is investigating potential claims against Medline Industries, Inc. (NASDAQ: MDLN) following a significant drop in its stock price. This investigation stems from a U.S. Food and Drug Administration (FDA) warning letter on June 2, 2026, citing "significant violations

Tone
Negative 28/100
Event
Regulatory and legal
Published
18 Jun 2026 10:00
Source
PR Newswire
NewMediaWire Direct company coverage

Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations after the FDA issued a warning letter citing "significant violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals." Following this n

Tone
Negative 30/100
Event
Market update
Published
17 Jun 2026 16:10
Source
NewMediaWire
NewMediaWire Direct company coverage

Kaplan Fox Announces an Investigation Into Medline Inc. (NASDAQ: MDLN) for Possible Securities Law Violations

Kaplan Fox & Kilsheimer LLP has announced an investigation into Medline Inc. (NASDAQ: MDLN) for potential securities law violations following a warning letter from the FDA. The FDA cited "significant violations of Current Good Manufacturing Practice regulations" and failure to th

Tone
Negative 18/100
Event
Regulatory and legal
Published
16 Jun 2026 14:41
Source
NewMediaWire
Stock Titan Direct company coverage

Director Galanti awarded 5,387 RSUs at Medline (MDLN)

Medline Inc. director Richard A. Galanti was awarded 5,387 shares of Class A Common Stock as restricted stock units (RSUs) at a price of $0.00 per share, increasing his direct holdings to 16,392 shares. The RSUs have vesting conditions, with one part vesting on March 30, 2027, an

Tone
Neutral 50/100
Event
Market update
Published
16 Jun 2026 08:11
Source
Stock Titan
Stock Titan Direct company coverage

Medline (MDLN) director granted 5,387 Class A restricted stock units

Medline Inc. director Thomas W. Sweet reported an acquisition of 5,387 Class A restricted stock units (RSUs) on June 11, 2026, bringing his direct holdings to that amount. This RSU grant was at no cash cost and is part of director compensation. The filing also detailed a prior gr

Tone
Neutral 50/100
Event
Deals and strategy
Published
16 Jun 2026 08:11
Source
Stock Titan
NewMediaWire Direct company coverage

Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to an Investigation of Potential Securities Law Violations

Kaplan Fox & Kilsheimer LLP is investigating Medline Inc. (NASDAQ: MDLN) for potential securities law violations after the FDA issued a warning letter on May 28, 2026, citing significant violations of good manufacturing practices for pharmaceuticals, including failing to investig

Tone
Negative 26/100
Event
Regulatory and legal
Published
16 Jun 2026 00:11
Source
NewMediaWire
Stock Titan Direct company coverage

Medline (MDLN) director Todd Bluedorn receives 15,732 total RSU-based shares

Medline Inc. director Todd M. Bluedorn has been granted 15,732 shares through restricted stock units (RSUs), rather than open-market purchases. This total includes a recent grant of 5,387 Class A Common Stock RSUs on June 11, 2026, which vest on the earlier of one year or the nex

Tone
Neutral 50/100
Event
Market update
Published
15 Jun 2026 22:11
Source
Stock Titan
marketscreener.com Direct company coverage

Certain Class A Common Stock of Medline Inc. are subject to a Lock-Up Agreement Ending on 15-JUN-2026.

Certain Class A Common Stock of Medline Inc. are under a lock-up agreement set to expire on June 15, 2026. This agreement, which began on December 16, 2025, restricts officers, directors, and pre-IPO owners from selling these shares for 181 days without prior consent from the und

Tone
Neutral 50/100
Event
Market update
Published
14 Jun 2026 08:36
Source
marketscreener.com
Stock Titan Direct company coverage

Medline (NASDAQ: MDLN) investors back directors, pay plan and EY auditor

Medline Inc. held its 2026 Annual Meeting of Stockholders on June 11, 2026, where all 12 director nominees were elected. Stockholders also approved the company's executive compensation on an advisory basis, supported an annual frequency for say-on-pay votes, and ratified Ernst &

Tone
Positive 73/100
Event
Market update
Published
12 Jun 2026 20:09
Source
Stock Titan
Morningstar Direct company coverage

MDLN Investors Have Opportunity to Join Medline Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm is investigating claims on behalf of investors of Medline Inc. (NASDAQ: MDLN) for potential securities law violations. This investigation stems from a Reuters report on June 3, 2026, which revealed that Medline received a second FDA warning in two months, citi

Tone
Negative 14/100
Event
Regulatory and legal
Published
11 Jun 2026 16:00
Source
Morningstar
Quiver Quantitative Direct company coverage

Medline shares rise as investors digest recent refinancing and large secondary offering | MDLN Stock News

Medline (MDLN) shares rose 6.9% following a recent debt refinancing and a large secondary share offering. Investors are likely reacting positively to the cleanup of near-term balance sheet and stock supply concerns, viewing funding risk and uncertainty around insider/PE selling a

Tone
Positive 71/100
Event
Balance sheet
Published
09 Jun 2026 21:21
Source
Quiver Quantitative